{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:42:47Z","timestamp":1786984967224,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK047987"],"award-info":[{"award-number":["DK047987"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK-MCD W1226"],"award-info":[{"award-number":["DK-MCD W1226"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007623","name":"Emory University School of Medicine","doi-asserted-by":"publisher","award":["DK047987"],"award-info":[{"award-number":["DK047987"]}],"id":[{"id":"10.13039\/100007623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007623","name":"Emory University School of Medicine","doi-asserted-by":"publisher","award":["DK-MCD W1226"],"award-info":[{"award-number":["DK-MCD W1226"]}],"id":[{"id":"10.13039\/100007623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["DK047987"],"award-info":[{"award-number":["DK047987"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["DK-MCD W1226"],"award-info":[{"award-number":["DK-MCD W1226"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"publisher","award":["DK047987"],"award-info":[{"award-number":["DK047987"]}],"id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"publisher","award":["DK-MCD W1226"],"award-info":[{"award-number":["DK-MCD W1226"]}],"id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK047987"],"award-info":[{"award-number":["DK047987"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK-MCD W1226"],"award-info":[{"award-number":["DK-MCD W1226"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bbadis.2021.166153","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T18:54:08Z","timestamp":1619117648000},"page":"166153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditions"],"prefix":"10.1016","volume":"1867","author":[{"given":"Alex","family":"Zaufel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.W.","family":"van de Wiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Fauler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Gilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan F.J.","family":"van de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbadis.2021.166153_bb0005","doi-asserted-by":"crossref","first-page":"G256","DOI":"10.1152\/ajpgi.00027.2007","article-title":"Human cecal bile acids: concentration and spectrum","volume":"293","author":"Hamilton","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166153_bb0010","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0016-5085(87)90430-6","article-title":"Simulation of the metabolism and enterohepatic circulation of endogenous deoxycholic acid in humans using a physiologic pharmacokinetic model for bile acid metabolism","volume":"93","author":"Hofmann","year":"1987","journal-title":"Gastroenterology"},{"issue":"7797","key":"10.1016\/j.bbadis.2021.166153_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41586-020-2047-9","article-title":"Global chemical effects of the microbiome include new bile-acid conjugations","volume":"579","author":"Quinn","year":"2020","journal-title":"Nature"},{"issue":"7456","key":"10.1016\/j.bbadis.2021.166153_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbadis.2021.166153_bb0025","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ijc.21365","article-title":"Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells","volume":"118","author":"Shah","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbadis.2021.166153_bb0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.bbadis.2021.166153_bb0035","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/hep.1840050611","article-title":"Transformation of bile acids into iso-bile acids by Clostridium perfringens: possible transport of 3 beta-hydrogen via the coenzyme","volume":"5","author":"Batta","year":"1985","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.bbadis.2021.166153_bb0040","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/gut.23.8.637","article-title":"Diurnal changes in serum unconjugated bile acids in normal man","volume":"23","author":"Setchell","year":"1982","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.bbadis.2021.166153_bb0045","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0021-9258(19)68206-2","article-title":"Metabolism of iso-bile acids in the rat","volume":"257","author":"Shefer","year":"1982","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bbadis.2021.166153_bb0050","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nchembio.1864","article-title":"A biosynthetic pathway for a prominent class of microbiota-derived bile acids","volume":"11","author":"Devlin","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166153_bb0055","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1074\/jbc.M110.181230","article-title":"AKR1B7 is induced by the farnesoid X receptor and metabolizes bile acids","volume":"286","author":"Schmidt","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bbadis.2021.166153_bb0060","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1016\/S0021-9258(18)32418-9","article-title":"The influence of bile salt structure on self-association in aqueous solutions","volume":"258","author":"Roda","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2021.166153_bb0065","doi-asserted-by":"crossref","unstructured":"Keely, S.J., et al., Bile acid-induced secretion in polarized monolayers of T84 colonic epithelial cells: structure-activity relationships. Am. J. Physiol. Gastrointest. Liver Physiol., 2007. 292(1): p. G290\u20137.","DOI":"10.1152\/ajpgi.00076.2006"},{"issue":"7785","key":"10.1016\/j.bbadis.2021.166153_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control TH17 and Treg cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"issue":"7809","key":"10.1016\/j.bbadis.2021.166153_bb0075","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","article-title":"Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells","volume":"581","author":"Campbell","year":"2020","journal-title":"Nature"},{"issue":"7790","key":"10.1016\/j.bbadis.2021.166153_bb0080","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut RORgamma(+) regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2021.166153_bb0085","doi-asserted-by":"crossref","unstructured":"Sayin, S.I., et al., Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab., 2013. 17(2): p. 225\u201335.","DOI":"10.1016\/j.cmet.2013.01.003"},{"issue":"4","key":"10.1016\/j.bbadis.2021.166153_bb0090","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","article-title":"Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism","volume":"33","author":"Zheng","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2021.166153_bb0095","doi-asserted-by":"crossref","unstructured":"Shea, H.C., et al., Analysis of HSD3B7 knockout mice reveals that a 3alpha-hydroxyl stereochemistry is required for bile acid function. Proc. Natl. Acad. Sci. U. S. A., 2007. 104(28): p. 11526\u201333.","DOI":"10.1073\/pnas.0705089104"},{"key":"10.1016\/j.bbadis.2021.166153_bb0100","doi-asserted-by":"crossref","unstructured":"Lan, T., et al., Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism. J. Hepatol., 2012. 57(2): p. 359\u201365.","DOI":"10.1016\/j.jhep.2012.03.025"},{"issue":"4","key":"10.1016\/j.bbadis.2021.166153_bb0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcmgh.2018.01.006","article-title":"Organic solute transporter alpha-beta protects Ileal enterocytes from bile acid-induced injury","volume":"5","author":"Ferrebee","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.bbadis.2021.166153_bb0110","doi-asserted-by":"crossref","unstructured":"van der Velden, L.M., et al., Monitoring bile acid transport in single living cells using a genetically encoded Forster resonance energy transfer sensor. Hepatology, 2013. 57(2): p. 740\u201352.","DOI":"10.1002\/hep.26012"},{"issue":"107","key":"10.1016\/j.bbadis.2021.166153_bb0115","doi-asserted-by":"crossref","DOI":"10.3791\/53659","article-title":"Real time monitoring of intracellular bile acid dynamics using a genetically encoded FRET-based bile acid sensor","author":"Van de Wiel","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"21","key":"10.1016\/j.bbadis.2021.166153_bb0120","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1073\/pnas.1903316116","article-title":"MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus","volume":"116","author":"Meixiong","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2021.166153_bb0125","doi-asserted-by":"crossref","unstructured":"Fickert, P., et al., Differential effects of norUDCA and UDCA in obstructive cholestasis in mice. J. Hepatol., 2013. 58(6): p. 1201\u20138.","DOI":"10.1016\/j.jhep.2013.01.026"},{"key":"10.1016\/j.bbadis.2021.166153_bb0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cca.2016.11.014","article-title":"Bile acid preparation and comprehensive analysis by high performance liquid chromatography-high-resolution mass spectrometry","volume":"464","author":"Amplatz","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2021.166153_bb0135","doi-asserted-by":"crossref","unstructured":"Bahar Halpern, K., et al., Nuclear retention of mRNA in mammalian tissues. Cell Rep., 2015. 13(12): p. 2653\u201362.","DOI":"10.1016\/j.celrep.2015.11.036"},{"key":"10.1016\/j.bbadis.2021.166153_bb0140","doi-asserted-by":"crossref","unstructured":"Hofmann, A.F. and L.R. Hagey, Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades. J. Lipid Res., 2014. 55(8): p. 1553\u201395.","DOI":"10.1194\/jlr.R049437"},{"key":"10.1016\/j.bbadis.2021.166153_bb0145","doi-asserted-by":"crossref","unstructured":"Han, J., et al., Metabolic profiling of bile acids in human and mouse blood by LC-MS\/MS in combination with phospholipid-depletion solid-phase extraction. Anal. Chem., 2015. 87(2): p. 1127\u201336.","DOI":"10.1021\/ac503816u"},{"key":"10.1016\/j.bbadis.2021.166153_bb0150","doi-asserted-by":"crossref","unstructured":"Lan, K., et al., Key role for the 12-Hydroxy Group in the Negative ion Fragmentation of unconjugated C24 bile acids. Anal. Chem., 2016. 88(14): p. 7041\u20138.","DOI":"10.1021\/acs.analchem.6b00573"},{"key":"10.1016\/j.bbadis.2021.166153_bb0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.anaerobe.2017.03.004","article-title":"Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids","volume":"45","author":"Thanissery","year":"2017","journal-title":"Anaerobe"},{"issue":"23","key":"10.1016\/j.bbadis.2021.166153_bb0160","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1007\/s00216-017-0489-1","article-title":"Factors affecting separation and detection of bile acids by liquid chromatography coupled with mass spectrometry in negative mode","volume":"409","author":"Yin","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"issue":"2\u20133","key":"10.1016\/j.bbadis.2021.166153_bb0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0378-4274(92)90156-E","article-title":"Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo and in vitro studies","volume":"61","author":"Delzenne","year":"1992","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166153_bb0170","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1038\/s41598-020-60821-w","article-title":"Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy","volume":"10","author":"Ovadia","year":"2020","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.bbadis.2021.166153_bb0175","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1016\/j.bmc.2016.06.039","article-title":"Novel FXR (farnesoid X receptor) modulators: potential therapies for cholesterol gallstone disease","volume":"24","author":"Yu","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166153_bb0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.taap.2014.12.005","article-title":"Individual bile acids have differential effects on bile acid signaling in mice","volume":"283","author":"Song","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbadis.2021.166153_bb0185","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1172\/JCI94029","article-title":"RNA-binding protein ZFP36L1 maintains posttranscriptional regulation of bile acid metabolism","volume":"127","author":"Tarling","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2021.166153_bb0190","doi-asserted-by":"crossref","unstructured":"Sato, H., et al., Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J. Med. Chem., 2008. 51(6): p. 1831\u201341.","DOI":"10.1021\/jm7015864"},{"key":"10.1016\/j.bbadis.2021.166153_bb0195","doi-asserted-by":"crossref","unstructured":"Fujino, T., et al., Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation. J. Lipid Res., 2004. 45(1): p. 132\u20138.","DOI":"10.1194\/jlr.M300215-JLR200"},{"key":"10.1016\/j.bbadis.2021.166153_bb0200","doi-asserted-by":"crossref","unstructured":"Lew, J.L., et al., The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion. J. Biol. Chem., 2004. 279(10): p. 8856\u201361.","DOI":"10.1074\/jbc.M306422200"},{"key":"10.1016\/j.bbadis.2021.166153_bb0205","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/msb.2011.62","article-title":"Coupled pre-mRNA and mRNA dynamics unveil operational strategies underlying transcriptional responses to stimuli","volume":"7","author":"Zeisel","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.bbadis.2021.166153_bb0210","doi-asserted-by":"crossref","unstructured":"Gabler, M., et al., Allosteric modulation of the farnesoid X receptor by a small molecule. Sci. Rep., 208. 8(1): p. 6846.","DOI":"10.1038\/s41598-018-25158-5"},{"key":"10.1016\/j.bbadis.2021.166153_bb0215","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pharmthera.2018.06.009","article-title":"Progress and challenges of selective Farnesoid X receptor modulation","volume":"191","author":"Massafra","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166153_bb0220","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1038\/s41467-019-10853-2","article-title":"Molecular tuning of farnesoid X receptor partial agonism","volume":"10","author":"Merk","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2021.166153_bb0225","doi-asserted-by":"crossref","unstructured":"Fang, C., F.V. Filipp, and J.W. Smith, Unusual binding of ursodeoxycholic acid to ileal bile acid binding protein: role in activation of FXRalpha. J. Lipid Res., 2012. 53(4): p. 664\u201373.","DOI":"10.1194\/jlr.M021733"},{"key":"10.1016\/j.bbadis.2021.166153_bb0230","doi-asserted-by":"crossref","unstructured":"Gonzalez, P.M., et al., Structural requirements of the human sodium-dependent bile acid transporter (hASBT): role of 3- and 7-OH moieties on binding and translocation of bile acids. Mol. Pharm., 2014. 11(2): p. 588\u201398.","DOI":"10.1021\/mp400575t"},{"key":"10.1016\/j.bbadis.2021.166153_bb0235","doi-asserted-by":"crossref","unstructured":"Gardes, C., et al., Studies in mice, hamsters, and rats demonstrate that repression of hepatic apoA-I expression by taurocholic acid in mice is not mediated by the farnesoid-X-receptor. J. Lipid Res., 2011. 52(6): p. 1188\u201399.","DOI":"10.1194\/jlr.M012542"},{"issue":"12","key":"10.1016\/j.bbadis.2021.166153_bb0240","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166153_bb0245","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0168-8278(97)80254-1","article-title":"Study of human isoursodeoxycholic acid metabolism","volume":"26","author":"Marschall","year":"1997","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bbadis.2021.166153_bb0250","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0304-4165(01)00096-4","article-title":"Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats","volume":"1526","author":"Purucker","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2021.166153_bb0255","doi-asserted-by":"crossref","unstructured":"Marschall, H.U., et al., Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis. J. Lipid Res., 2001. 42(5): p. 735\u201342.","DOI":"10.1016\/S0022-2275(20)31635-7"},{"issue":"4","key":"10.1016\/j.bbadis.2021.166153_bb0260","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1172\/JCI64551","article-title":"The TGR5 receptor mediates bile acid-induced itch and analgesia","volume":"123","author":"Alemi","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bbadis.2021.166153_bb0265","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bbadis.2021.166153_bb0270","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bbadis.2021.166153_bb0275","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.30509","article-title":"The nonsteroidal Farnesoid X receptor agonist Cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with primary Sclerosing cholangitis","volume":"70","author":"Trauner","year":"2019","journal-title":"Hepatology"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443921000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443921000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:03:25Z","timestamp":1760418205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443921000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0925443921000867"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2021.166153","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditions","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2021.166153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166153"}}